J Korean Ophthalmol Soc.  2012 Dec;53(12):1823-1827. 10.3341/jkos.2012.53.12.1823.

Complication Incidence of Day Surgeries with 23 Gauge Vitrectomy

• Lee GW
• Na SJ
• Lee YH
• Jin SY
• Lee TG

• KMID: 2216397
• DOI: http://doi.org/10.3341/jkos.2012.53.12.1823

Abstract

PURPOSE
To evaluate the complication incidence of 23-gauge pars plana vitrectomy day surgery.
METHODS
A retrospective review was conducted on 79 eyes that underwent 23-gauge pars plana vitrectomy day surgery from September 2009 to September 2010. The main outcome measures included changes in best corrected visual acuity (BCVA), intraocular pressure (IOP), and presence of postoperative complications after the day surgery.
RESULTS
The mean preoperative log MAR BCVA improved from 1.32 +/- 0.96 to 0.40 +/- 0.41 at 3 months after surgery (p < 0.05). There was no significant differences between the mean preoperative IOP and IOP on the 1st day after surgery (p > 0.05). At the end of surgery, suture placement was required for sclerotomy site leakage in 4 eyes (5.1%). There were 10 eyes (12.7%) with postoperative complications, including 7 eyes with increased IOP (8.9%), hypotony in 2 eyes (2.6%) and vitreous hemorrhage in 1 eye (1.3%), with no case requiring reoperation.
CONCLUSIONS
The patients who underwent 23-gauge pars plana vitrectomy day surgery achieved visual improvement without serious complications postoperatively.

Keyword

Day Surgery; 23-gauge Vitrectomy

MeSH Terms

Ambulatory Surgical Procedures
Eye
Humans
Incidence
Intraocular Pressure
Outcome Assessment (Health Care)
Postoperative Complications
Retrospective Studies
Sutures
Visual Acuity
Vitrectomy
Vitreous Hemorrhage

Reference

1. Kelman CD. Phaco-emulsification and aspiration. A new technique of cataract removal. A preliminary report. Am J Ophthalmol. 1967. 64:23–35.

2. Alio JL. Alio JL, Rodriguez Prats JL, Galal A, editors. What does MICS require? MICS Micro-incision Cataract Surgery. 2004. Miami: Highlights of Ophthalmology;1–4.

3. Lee DY, Roh JH, Shyn KH. 2005 Survey for KSCRS Members: Current trends in cataract surgery in Korea. J Korean Ophthalmol Soc. 2007. 48:485–492.

4. Strong NP, Wigmore W, Smithson S, et al. Daycase cataract surgery. Br J Ophthalmol. 1991. 75:731–733.

5. Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971. 75:813–820.

6. Eckardt C. Transconjunctival sutureless 23-gauge Vitrectomy. Retina. 2005. 25:208–211.

7. Newsom RS, Wainwright AC, Canning CR. Local anaesthesia for 1221 vitreoretinal procedures. Br J Ophthalmol. 2001. 85:225–227.

8. Italian Society of Otorhinolaringology and Cervicofacial Surgery. [Clinical indicators for day hospital and day surgery managed otorhinolaryngologic and cervicofacial diseases. Update 2002]. Acta Otorhinolaryngol Ital. 2002. 22:5 Suppl 72. 1–13.

9. Lott MN, Manning MH, Singh J, et al. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications. Retina. 2008. 28:1193–1200.

10. Parolini B, Prigione G, Romanelli F, et al. Postoperative complications and intraocular pressure in 943 consecutive cases of 23-gauge transconjunctival pars plana vitrectomy with 1-year follow-up. Retina. 2010. 30:107–111.

11. Gupta OP, Ho AC, Kaiser PK, et al. Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2008. 146:193–197.

12. Han JI, Cho SW, Lee TG, et al. The clinical results of sutureless vitrectomy using 23-gauge surgical system. J Korean Ophthalmol Soc. 2008. 49:911–916.

13. Woo SJ, Park KH, Hwang JM, et al. Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy. Retina. 2009. 29:456–463.

14. Yang HK, Woo SJ, Park KH, Park KH. Intraocular pressure changes after vitrectomy with and without combined phacoemulsification and intraocular lens implantation. Korean J Ophthalmol. 2010. 24:341–346.

15. Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004. 138:740–743.

16. Chieh JJ, Rogers AH, Wiegand TW, et al. Short-term safety of 23-gauge single-step transconjunctival vitrectomy surgery. Retina. 2009. 29:1486–1490.

17. Cheema RA, Mushtaq J, Al-Khars W, et al. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage. Retina. 2010. 30:1646–1650.

18. Pineault R, Contandriopoulos AP, Valois M, et al. Randomized clinical trial of one-day surgery. Patient satisfaction, clinical outcomes, and costs. Med Care. 1985. 23:171–182.

19. Dzielicki J, Korlacki W, Skrzypiec W, Krzyśków M. [Economical benefits of one-day surgery treatment in children: 10 year of experience]. Wiad Lek. 1998. 51:474–479.

20. Vonberg RP, Weitzel-Kage D, Behnke M, Gastmeier P. Worldwide Outbreak Database: the largest collection of nosocomial outbreaks. Infection. 2011. 39:29–34.

21. Hilton GF, Josephberg RG, Halperin LS, et al. Office-based sutureless transconjunctival pars plana vitrectomy. Retina. 2002. 22:725–732.